Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sinopharm Group


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 4
Average round size
The average size of a deal this fund participated in
Portfolio companies 3
Rounds per year 0.17
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Biopharma
  • Life Science

Sinopharm Group appeared to be the Corporate Investor, which was created in 1998. The fund was located in Asia if to be more exact in China. The main office of represented Corporate Investor is situated in the Shanghai.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Sinopharm Group, startups are often financed by Versant Ventures, Tavistock Life Sciences, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are Northeast Securities, HOPU Investment Management Company, Everbright.

Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2016. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund.

We can highlight the next thriving fund investment areas, such as Life Science, Beauty. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Ambrx, GemPharmatech Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sinopharm Group:
Typical Co-investors
Sinopharm Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sinopharm Group:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A5 Capital Partners Brazil, São Paulo, Sao Paulo
Chengdu Kunde Touzi Chengdu, China, Sichuan
Coats plc Hillingdon, United Kingdom, Uxbridge
Denali Capital -
ES-CON Japan Japan, Minato
Javelin Venture Partners California, San Francisco, United States
K Street Capital District of Columbia, United States, Washington
MF Private Capital Boston, Massachusetts, United States
Mitsubishi Corporation Chiyoda, Japan
Montane Ventures India, Maharashtra, Mumbai -
Satya Capital England, London, United Kingdom
Sharp Japan, Toyama, Toyama Prefecture
Smithfield Smithfield, United States, Virginia
Spike Ventures California, Stanford, United States
[email protected] Kentucky, Louisville, United States
TPG Biotech California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
$24M02 Jul 2019 Xuanwu District, Jiangsu, China

07 Feb 2018 Shangcheng District, Zhejiang, China


Health Care
Life Science
$45M04 Aug 2016 San Diego, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sinopharm Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: